rs11047892

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001001660.3(ETFRF1):​c.*787T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0996 in 215,708 control chromosomes in the GnomAD database, including 1,542 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 1135 hom., cov: 33)
Exomes 𝑓: 0.097 ( 407 hom. )

Consequence

ETFRF1
NM_001001660.3 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.00300

Publications

8 publications found
Variant links:
Genes affected
ETFRF1 (HGNC:27052): (electron transfer flavoprotein regulatory factor 1) Involved in respiratory electron transport chain. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]
KRAS (HGNC:6407): (KRAS proto-oncogene, GTPase) This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]
KRAS Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, PanelApp Australia
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Noonan syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • linear nevus sebaceous syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.136 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ETFRF1NM_001001660.3 linkc.*787T>A 3_prime_UTR_variant Exon 3 of 3 ENST00000381356.9 NP_001001660.2 Q6IPR1
KRASNM_004985.5 linkc.*4696A>T downstream_gene_variant ENST00000311936.8 NP_004976.2 P01116-2A0A024RAV5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ETFRF1ENST00000381356.9 linkc.*787T>A 3_prime_UTR_variant Exon 3 of 3 1 NM_001001660.3 ENSP00000370761.4 Q6IPR1
KRASENST00000311936.8 linkc.*4696A>T downstream_gene_variant 1 NM_004985.5 ENSP00000308495.3 P01116-2

Frequencies

GnomAD3 genomes
AF:
0.101
AC:
15311
AN:
152026
Hom.:
1135
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0224
Gnomad AMI
AF:
0.0932
Gnomad AMR
AF:
0.0767
Gnomad ASJ
AF:
0.0608
Gnomad EAS
AF:
0.00212
Gnomad SAS
AF:
0.0970
Gnomad FIN
AF:
0.272
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.138
Gnomad OTH
AF:
0.0837
GnomAD4 exome
AF:
0.0971
AC:
6171
AN:
63564
Hom.:
407
Cov.:
0
AF XY:
0.0972
AC XY:
2867
AN XY:
29502
show subpopulations
African (AFR)
AF:
0.0229
AC:
67
AN:
2924
American (AMR)
AF:
0.0690
AC:
132
AN:
1912
Ashkenazi Jewish (ASJ)
AF:
0.0587
AC:
237
AN:
4040
East Asian (EAS)
AF:
0.000322
AC:
3
AN:
9318
South Asian (SAS)
AF:
0.110
AC:
62
AN:
564
European-Finnish (FIN)
AF:
0.272
AC:
112
AN:
412
Middle Eastern (MID)
AF:
0.0483
AC:
20
AN:
414
European-Non Finnish (NFE)
AF:
0.130
AC:
5023
AN:
38666
Other (OTH)
AF:
0.0969
AC:
515
AN:
5314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
268
535
803
1070
1338
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.101
AC:
15305
AN:
152144
Hom.:
1135
Cov.:
33
AF XY:
0.105
AC XY:
7835
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.0223
AC:
927
AN:
41556
American (AMR)
AF:
0.0766
AC:
1170
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0608
AC:
211
AN:
3470
East Asian (EAS)
AF:
0.00212
AC:
11
AN:
5186
South Asian (SAS)
AF:
0.0969
AC:
467
AN:
4820
European-Finnish (FIN)
AF:
0.272
AC:
2873
AN:
10570
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.138
AC:
9371
AN:
67940
Other (OTH)
AF:
0.0828
AC:
175
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
684
1368
2051
2735
3419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0696
Hom.:
114
Bravo
AF:
0.0832
Asia WGS
AF:
0.0390
AC:
137
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.9
DANN
Benign
0.69
PhyloP100
-0.0030
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11047892; hg19: chr12-25358033; API